Apricus Biosciences

Apricus Biosciences is a biopharmaceutical company which focuses on the development and commercialization of product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. The Company also engages in developing other medicines to treat rheumatoid and urological disease.

Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1987
Size (employees)
15 (est)
Apricus Biosciences was founded in 1987 and is headquartered in San Diego, US

Apricus Biosciences Office Locations

Apricus Biosciences has an office in San Diego
San Diego, US (HQ)
11975 El Camino Real, Ste 300
Show all (1)

Apricus Biosciences Financials and Metrics

Apricus Biosciences Financials

Apricus Biosciences's revenue was reported to be $5.8 m in FY, 2016
USD

Net income (Q3, 2017)

(3.8 m)

Market capitalization (22-Dec-2017)

24 m

Cash (30-Sep-2017)

8.5 m
Apricus Biosciences's current market capitalization is $24 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

2.5 m9.3 m4.8 m5.8 m

Revenue growth, %

269%(48%)19%

Cost of goods sold

23 k918 k922 k511 k

Gross profit

2.5 m8.3 m3.9 m5.3 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

28 k5.5 m1.9 m475 k462 k1.3 m626 k464 k4.3 m

Cost of goods sold

75 k485 k233 k509 k142 k233 k93 k111 k

Gross profit

5.4 m1.4 m242 k(47 k)1.1 m393 k371 k4.2 m

Gross profit Margin, %

99%74%51%(10%)89%63%80%97%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

21.4 m11.4 m3.9 m2.1 m

Accounts Receivable

59 k678 k519 k530 k

Inventories

336 k275 k469 k764 k

Current Assets

22.3 m13.3 m6.3 m3.6 m
USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

20.6 m22.5 m17.4 m16.2 m7.4 m5.8 m6.9 m2.7 m5.6 m3.8 m7.8 m8.5 m

Accounts Receivable

35 k69 k49 k513 k664 k575 k688 k687 k398 k

Inventories

338 k364 k377 k217 k411 k142 k405 k778 k800 k

Current Assets

21.7 m23.5 m18.8 m18 m9.8 m8.2 m9.1 m4.9 m7.2 m5.1 m8.6 m8.7 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(16.9 m)(21.8 m)(19 m)(7.4 m)

Depreciation and Amortization

77 k170 k300 k289 k

Accounts Receivable

253 k(620 k)159 k(11 k)

Inventories

(341 k)61 k(194 k)(295 k)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(15.6 m)(3.3 m)(1.4 m)(4.5 m)(6.4 m)(5 m)(2.5 m)(3.3 m)(7.1 m)8.1 m

Depreciation and Amortization

57 k20 k40 k102 k

Accounts Receivable

276 k(10 k)10 k(770 k)513 k664 k575 k688 k687 k398 k

Inventories

(338 k)(28 k)(41 k)15 k217 k411 k142 k405 k778 k800 k
Y, 2017

Financial Leverage

1.4 x
Show all financial metrics

Apricus Biosciences Market Value History

Apricus Biosciences's Web-traffic and Trends

Apricus Biosciences Online and Social Media Presence

Apricus Biosciences Company Life and Culture

You may also be interested in